Search Results - D. A. Kaperko

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Canagliflozin and risk of amputation in patients with type 2 diabetes

    Canagliflozin and risk of amputation in patients with type 2 diabetes by T. M. Bukatina, A. S. Kazakov, D. A. Kaperko, T. V. Romanova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents

    Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents by E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko, G. V. Kutekhova

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting

    Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting by S. L. Morokhina, R. N. Alyautdin, D. A. Kaperko, E. V. Shubnikova, I. I. Snegireva, Yu. A. Smirnova

    Published 2018-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS

    POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS by E. V. Shubnikova, T. M. Bukatina, D. A. Kaperko, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    The Adverse Drug Reactions Registered During the Postmarketing Period

    The Adverse Drug Reactions Registered During the Postmarketing Period by E. V. Shubnikova, M. A. Darmostukova, T. M. Bukatina, D. A. Kaperko, N. Y. Velts, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    International Drug Safety Monitoring

    International Drug Safety Monitoring by A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4

    UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 by T. V. Romanova, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, I. I. Snegireva, M. A. Darmostukova, D. A. Kaperko, N. Yu. Velts, A. S. Kazakov, E. V. Shubnikova, R. N. Alyautdin

    Published 2018-06-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Analysis of the decisions of foreign regulatory authorities

    Analysis of the decisions of foreign regulatory authorities by T. M. Bukatina, E. Yu. Pasternak, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. S. Kazakov, K. E. Zatolochina, I. I. Snegireva, M. A. Darmostukova, E. O. Zhuravleva, T. V. Romanova, N. Yu. Velts, M. L. Maksimov, D. A. Kaperko, G. V. Kutekhova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Analysis of the decisions of foreign regulatory authorities

    Analysis of the decisions of foreign regulatory authorities by T. M. Bukatina, E. Yu. Pasternak, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. S. Kazakov, K. E. Zatolochina, I. I. Snegireva, M. A. Darmostukova, E. O. Zhuravleva, T. V. Romanova, N. Yu. Velts, M. L. Maximov, D. A. Kaperko, G. V. Kutekhova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: